被称为“AI慢病管理第一股”的方舟健客(6086.HK)盘中拉升涨超16%，报4.35港元，股价创近4个月新高。 消息面上，方舟健客发布业绩显示，2025年上半年收入14.94亿，同比增长12.9%；净利润实现扭亏为盈，达1250万元；经调整净利润再创新高，达1760万元，同比增长16.8%。公司在主营业务上取得显著进展。其中，线上零售药店服务收入8.64亿元，同比大幅增长28.2%；综合医疗服务业务收入实现3.57亿元，同比增长11.4%。 近日，花旗发布研报首次覆盖方舟健客。花旗指出，建立在长期医患关系基础上，方舟健客拥有忠诚且活跃的付费用户群，用户复购率高且支付意愿强，给予“买入”评级，目标价8.5港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.